 MINNEAPOLIS, June 28, 2021 PRNewswire -- Goodness Growth Holdings, Inc. Goodness Growth or the Company CSE: GDNS; OTCQX: GDNSF, a physician-led, science-focused cannabis company and IP incubator, today announced that its subsidiary, Resurgent Biosciences Resurgent, has filed for a U.S. patent to create an expansive suite of virtual reality VR applications that can be used by practitioners during psychedelic-based therapies to enhance and guide patients through the experience and potentially create optimized, longer-lasting therapeutic outcomes. One of the largest unmet needs in the psychedelic space is a scalable platform that will allow medical practitioners to administer psychedelic medicine remotely in a consistent and controlled environment. 